Sodium-Glucose Co-Transporter-2 Inhibitors in Type 1 Diabetes: A Scoping Review

BACKGROUND: With recent developments in diabetes technology, attaining adequate glucose control is more achievable than ever. Despite these improvements, a significant proportion of individuals with type 1 diabetes do not reach recommended glycaemic goals. Sodium-glucose co-transporter-2 (SGLT2) inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Hropot, Tim, Battelino, Tadej, Dovc, Klemen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652647/
https://www.ncbi.nlm.nih.gov/pubmed/36279850
http://dx.doi.org/10.1159/000527653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652647/
https://www.ncbi.nlm.nih.gov/pubmed/36279850
http://dx.doi.org/10.1159/000527653

Ejemplares similares